newsfilter
← Latest News
GlobeNewswire·

Morphic Appoints Dr. Simon Cooper as Chief Medical Officer

WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases,